Coronavirus (COVID-19), CBER-Regulated Biologics

This page and the associated links provide information on guidance and advice relevant to the development of therapies to treat or prevent COVID-19, and contact information for developers seeking additional information or assistance.

Immunogenicity of NVX-CoV2373 heterologous boost against SARS-CoV

Elsevier – Clinical Overviews │ Coronavirus │ COVID-19

Special Feature: US FDA's Coronavirus Treatment Acceleration

Advances in COVID-19 mRNA vaccine development

Vaccines, Free Full-Text

Vaccines, Free Full-Text

New COVID-19 Vaccines Will Keep Pharmacy Staff Busy

FDA Amends Novavax COVID-19 Vaccine EUA to Include 2023-2024

SARS-CoV-2 Omicron XBB lineage spike structures, conformations

Assessment of adverse events among healthcare workers following